News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • ORR shared leads with ICE during Trump's second term, linked to over 12,000 arrests and prolonged shelter custody for minors.
  • An AI-generated avatar of jailed Bolsonaro spoke at his son's campaign launch, triggering immediate legal challenges over synthetic political messaging.
  • QatarEnergy extended LNG force majeure through September, forcing Edison to replace cargoes and pressuring European gas supply and prices.
  • Bundesbank sees modest Q2 German GDP growth despite Middle East war, but cautions the conflict will remain a drag.
  • TransUnion beat Q2 guidance with 15% revenue growth, raised full-year revenue forecast to 12-13% and increased buybacks.
  • INNIO reported a record $2.3bn equipment order intake and raised 2026 revenue and adjusted EBITDA guidance despite a Q2 net loss.

Latest Articles

Syndax Announces Participation in Upcoming Investor Conferences

Syndax Announces Participation in Upcoming Investor Conferences

Syndax Pharmaceuticals, a commercial-stage biopharmaceutical company focused on cancer therapies, announced that CEO Michael A. Metzger and management will participate in several upcoming investor conferences including the TD Cowen Oncology Innovation Summit, Jefferies Global Healthcare Conference, and Goldman Sachs Global Healthcare Conference. Th…

C4 Therapeutics to Participate in Upcoming Conferences

C4 Therapeutics to Participate in Upcoming Conferences

C4 Therapeutics, a clinical-stage biopharmaceutical company focused on targeted protein degradation, announced its management team's participation in several upcoming healthcare and oncology investment conferences. These events include TD Cowen's Oncology Innovation Summit, Jefferies Global Healthcare Conference, and Goldman Sachs Global Healthcare…

Sachem Capital Reports First Quarter 2026 Results

Sachem Capital Reports First Quarter 2026 Results

Sachem Capital Corp., a mortgage REIT, reported its Q1 2026 financial results highlighting disciplined capital management and ongoing legacy loan resolutions. The company announced a transformative contribution agreement with Industrial Realty Group to combine 98 industrial assets, forming a larger industrial REIT named IRG Realty Trust with an est…

30 MW Barrow Green Hydrogen Project Achieves Final Investment Decision with Plug Power Electrolyzer Supply

30 MW Barrow Green Hydrogen Project Achieves Final Investment Decision with Plug Power Electrolyzer Supply

Plug Power announced the final investment decision for the 30 MW Barrow Green Hydrogen project in the UK, where it will supply GenEco PEM electrolyzers. The project, delivered by the Green Hydrogen Energy Company joint venture, aims to produce green hydrogen to supply Kimberly-Clark's manufacturing plant, significantly reducing natural gas consumpt…

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026

Immunovant, Inc. announced positive preliminary results from its IMVT-1402 trial in difficult-to-treat rheumatoid arthritis demonstrating meaningful clinical response rates. The company also reported financial results for the quarter and fiscal year ended March 31, 2026, highlighted a strong cash position to support continued development and potent…

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update

Roivant Sciences reported robust clinical trial results for IMVT-1402 in difficult-to-treat rheumatoid arthritis, received Breakthrough Therapy Designation for brepocitinib in cutaneous sarcoidosis, and anticipates multiple upcoming clinical and commercial milestones. The company also announced a $2.25 billion global settlement with Moderna, signif…

Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1

Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1

Skye Bioscience announced that the Cohort Review Committee has approved opening Cohort 2 of their CBeyond Part C Expansion study, escalating nimacimab dosage from 400 mg IV to 600 mg IV weekly. This decision is based on favorable safety data from the first four participants in Cohort 1, with no neuropsychiatric adverse events reported so far. The s…

AmpliTech Group Receives FCC and Canadian Certifications for Indoor 5G Infrastructure Supporting Next-Generation Wireless Coverage for Homes, Businesses, and Public Facilities

AmpliTech Group Receives FCC and Canadian Certifications for Indoor 5G Infrastructure Supporting Next-Generation Wireless Coverage for Homes, Businesses, and Public Facilities

AmpliTech Group, Inc. announced it has received full FCC and Canadian ISED certifications for its complete 5G Native Distributed Antenna System (DAS) solution, allowing immediate commercial sale and deployment across North America. The certifications cover AmpliTech's entire hardware stack, including 5G Pico Radios and Hubs, supporting expanded Fix…

GDS Holdings Limited Reports First Quarter 2026 Results

GDS Holdings Limited Reports First Quarter 2026 Results

GDS Holdings Limited, a leading data center operator in China, reported robust Q1 2026 results with net revenue up 23.6% year-over-year to RMB3.37 billion and net income soaring 247.1% to RMB2.65 billion. Adjusted EBITDA also rose significantly by 47.2% year-over-year. The company enhanced financial flexibility through share sales and private place…

HSBC Urges Staff to Accept AI Change as Banks Reveal Job Reductions

HSBC Urges Staff to Accept AI Change as Banks Reveal Job Reductions

Senior executives at major banks are telling employees to adapt to generative AI even as firms begin to cut roles. HSBC's chief executive framed the technology as both a destroyer and creator of jobs, while Standard Chartered announced plans to remove nearly 8,000 positions and to reduce certain corporate functions by 15% by 2030. Analysts and acad…

Jeep Cherokee Hybrid Sales Lag as Ram Drives Stellantis’ Early Gains

Jeep Cherokee Hybrid Sales Lag as Ram Drives Stellantis’ Early Gains

Stellantis returned to profitability in the first quarter and saw strong demand for its Ram trucks, but Jeep’s newly relaunched Cherokee hybrid has delivered only modest sales, testing the company’s turnaround plans under CEO Antonio Filosa. Elevated costs, tariffs and production constraints are weighing on the compact SUV’s early performance even …

Golar LNG Limited Interim results for the period ended March 31, 2026

Golar LNG Limited Interim results for the period ended March 31, 2026

Golar LNG Limited announces robust financial performance for Q1 2026 with net income attributable to the company at $84 million and Adjusted EBITDA of $106 million. Operational highlights include FLNG Hilli offloading its 150th cargo and FLNG Gimi exceeding contracted volumes by 19%. The MKII FLNG conversion project remains on time and within budge…

Occidental: Buyback- and Dividend-Led Trade as Oil Keeps the Tailwind

Occidental: Buyback- and Dividend-Led Trade as Oil Keeps the Tailwind

Occidental Petroleum is shifting from rebuild to returns. Strong free cash flow from elevated oil prices, a recent $9.7B divestiture and materially lower debt give the board flexibility to increase dividends and buybacks. For active traders, a mid-term long (45 trading days) targeting $75 captures both cash-return rerating and continued strength in…